WeVote
Log In

Bill

Bill

S 1607

Relates to landowner recreational liability and farm and horseback riding operation liability relief; and enacts the "equine activity safety code act"

2025 Regular Session Introduced by George Borrello and 1 co-sponsor

INSPECT Act aims to boost national safety, public health protections, ethics standards, and stronger oversight of clinical trials to protect participants.

REFERRED TO JUDICIARY
0
WeVote Research Nonpartisan
Bill Summary · S 1607

INSPECT Act (S. 1607) — Summary

Overview

The INSPECT Act is a bill introduced in the Senate on May 6, 2025, formally titled the Improving National Safety, Public Health, Ethics, and Clinical Trials Act. The short title suggests a focus on enhancing safety, public health protections, ethics standards, and oversight of clinical trials.

Basic Details

  • Bill Number: S. 1607
  • Official Short Title: INSPECT Act (Improving National Safety, Public health, Ethics, and Clinical Trials Act)
  • Status: Introduced in Senate
  • Introduced: May 6, 2025
  • Primary Sponsor: Senator Eric S. Schmitt
  • Committee Action (so far): Read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions (HELP) on May 6, 2025

What the introduced text contains

  • The only content provided for this version is the short title and formal citation, indicating the bill’s aim as per its name. No detailed provisions, sections, or fiscal notes are included in the available material.

Potentialscope and implications (based on the title)

Because the substantive text is not included in the provided material, specific provisions are not listed. Based on the bill’s title, the INSPECT Act likely aims to address:
- National safety and public health measures
- Ethics standards in research and healthcare
- Oversight and governance related to clinical trials

Possible areas of impact (subject to the actual text): ethics frameworks for clinical trials, oversight/monitoring mechanisms, transparency and reporting requirements, protections for participants, and potential funding or agency responsibilities to improve safety and ethics in research.

Procedural timeline and next steps

  • After introduction, the bill was referred to the Senate Committee on Health, Education, Labor, and Pensions (HELP) for consideration.
  • If advanced, the bill could proceed to committee hearings, markups, and a committee vote.
  • Success in HELP would move the measure to the Senate floor for debate and a potential vote.
  • If enacted, the bill would proceed through the legislative process in the House (if a companion House bill exists) and, ultimately, to the President for signature or veto.

Notes for readers

  • The current information set provides only the introductory metadata and sponsor, with no text-level provisions. For a complete understanding of the bill’s impact, the committee’s written summary, the full text of the introduced version, and any subsequent amendments would be necessary.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.